Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
what is the most important part of urate production
|
- PRPP and glutamine
- the enzyme that controls them making iosinic acid, PRPP aminotransferase |
|
what controls PRPP aminotransferase
|
negative feedback by purine nucleosides
|
|
what is the deal with purine salvage
|
- when purines that would be converted to urate are lost for incorporation into nucleic acids
- the enzyme HGPRTase is what send them into this (so it sends them away from gout) |
|
Lesch-Nyhan syndrome
|
- decreased HGPRTase
- increased de novo urate synthesis from too much PRPP not used in salvaging purine bases |
|
how do gout pts excrete urate as a group?
|
- they tend to excrete 40% less, even thought their blood levels are high
- some 20% secrete more than average |
|
how much urate does a gout person have in their system?
|
- normal is 1 g
- w/out tophi is 4 g - w/ tophi, 15-30 g |
|
2o causes of gout
|
- increased nucleic acid turnover (myeloprolif disorders)
- Lesch-Nyhan syndrome - von Gierke's disease - renal failure - moonshine drinking - metabolic acidosis, ketoacidosis, salycylates competing for PT in kidney |
|
how does the synovial fluid react with MSU?
|
- The FC of IgG is available to the PNN FC-R, which leads to adherance and phagocytosis
- Haegmen Factor, C1, C3, and C4 can also be bound and activated |
|
how do PMN's react with MSU?
|
- MSU is way bigger, so more incomplete phagogenesis a membrane rupture --> lysosomes released
- if fully phagocytized, MSU destroys the membrane of the phagolysosome, so increased fluid levels of lysozymes - crystal chemotactic factor is released from PMN's which attracts other PMN's |
|
podagra
|
gout of 1st MTP
|
|
gout labs
|
- not diganostic!
- but, increased UA - leukocytosis w/ immature PMNs (left shift) - sed rate up - serum acute phase reactants (will look like infectious arthritis) - synovial viscocity is less than RA or ifectious A |
|
colchicine
|
- for acute tx of gout, or prophylacticaly to prevent multiple attacks
- inhibits PMN microtubular function (at super high doses) - inhibits MSU-incuded chemotactic factor release |
|
allopurinol
|
- purine antimetabolite to block purine degradation for that feedback inhibition of PRPP aminotransferase
- also blocks xanthine oxidase - high levels of oxypurinol |
|
probenecid
|
- uricosuric agent - blocks renal tubular reabsorption of uric acid, promotes urinary excretion
- not for people w/ high urine sed rate or increased urinary excretion, can cause nephrolithiasis |
|
tumor lysis syndrome
|
ARF from UA precipitates lodging in DT and CD
|
|
pseudogout clinical
|
- from CPPD
- older, more women than gout - less mild than gout - knees, wrists, elbows, shoulders, pubic symphysis - deposits not seen on PE |
|
diseases associated w/ pseudogout
|
- hyperPT, hypoT
- hemochromatosis - ochronosis - pagets - DM - OA - hypoMag |
|
chondrocalcinosis
|
CPPD depositis in cartilage of tendons and ligaments
|
|
tx of pseudogout
|
- rest
- NSAID (indomethacin) - joint aspiration |
|
other crystals that can cause arthritis
|
- Ca - can cause tophi, in inflamed joints and bursae
- apitate (mineral of bone) - purple rounded inclusions on PMN's |